ArticleJournal of ophthalmology2026
Effect of 25-Gauge Needle-Assisted Phacoemulsification of Dislocated Intravitreal Lens Nucleus.
Article in Journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effect of 25-Gauge Needle-Assisted Phacoemulsification of Dislocated Intravitreal Lens Nucleus.Journal of ophthalmology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Purpose: To present and evaluate the effect of a novel technique, 25-gauge (G) needle-assisted phacoemulsification, to remove dislocated intravitreal lens nuclei. Methods: Methods: Nine eyes of nine patients with dislocated intravitreal lens nuclei who underwent 23-G pars plana vitrectomy (PPV) and 25-G needle-assisted phacoemulsification between July 2022 and September 2024 were included in this study. Best-corrected visual acuity (BCVA), intraocular pressure (IOP) and corneal endothelial cell count (CECC) were statistically analysed both preoperatively and postoperatively. The intraoperative and postoperative complications were evaluated. A minimum follow-up of 6 months was completed for all eyes. Results: Results: All nine eyes of nine patients were successfully treated with 23-G PPV and 25-G needle-assisted phacoemulsification and postoperatively followed up for 6-13 months. BCVA improved significantly ( Conclusion: Conclusion: The 25-G needle-assisted phacoemulsification is a safe and efficient alternative for removing dislocated intravitreal lens nuclei.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.